TTEN·K/calls
Pinned
  • The Brief
  • Congress
  • Screener
  • Markets
  • The Brief
  • Signal Confluence
  • The Flip Side
  • Markets
  • Calendar
  • Coverage
  • Screener
  • Discover
  • Smart Money
  • Congress
  • Insiders
  • IPOs
  • ETF Holdings
  • 13F Funds
  • Events
  • Filings
  • News
  • Trending
  • Groups
  • Data catalog
  • Research
  • Education
  • Options Plays
  • Options Calculator
  • Leaderboards
  • Compare
  • Portfolio
  • Strategies
  • Track
  • Pricing
  • API
  • Newsletter
  • Follow the calls
  • Feedback
  • Account
Go ProUpgrade →
TTEN·K/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Telegram ↗X ↗Bluesky ↗Follow the calls →

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

MethodologyDisclosuresTermsPrivacy

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

← New search
Home›Coverage›CMIIU
On this page
OverviewValuationQualitySmart moneyTimelineFilings
CMIIU logo

CMIIUColumbus Circle Capital Corp II

Hold
Rating
Hold
Quality
F
Valuation
Fair value
Filings
Watch
How to read this →
HoldConservative balance sheet (liabilities/equity -8.31x).Liabilities / equity -8.31xFull call ↓
$10.95▲ +9.39%
over 1Y
L $9.94H $10.95
Our buy Our hold Our sell Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today
—
1W
+0.0%
1M
+7.5%
3M
+10.2%
YTD
+9.4%
1Y
+9.4%
OverviewValuationQualitySmart moneyTimelineFilings
Hold
Conviction
Horizon
Medium (3–12mo)

Conservative balance sheet (liabilities/equity -8.31x).

Liabilities / equity -8.31x · latest

This call stands until the filings change it — the engine re-rates on new 10-K/10-Q/8-K facts, never on price moves. Hit Watch above to follow CMIIU (Pro alerts fire the moment a rating flips), or catch every change in Saturday’s Flip Side. How to read a call

Columbus Circle Capital Corp II shows limited reported revenue.

Supporting the case: conservative balance sheet (liabilities/equity -8.31x).

Is CMIIU a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~65d expiry
  • Long 100 shares @ ~10.95
  • Short call 11.5 @ ~0.15 est
debit $1,080max +$70max −$1,079BE 10.80

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →
Browse all model plays →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financialsannual, by fiscal year

No income data filed.

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timelineSEC · 8-Ks + reports

Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-07-02
  2. 8-K Reg FD disclosure2026-06-26
  3. 10-Q Quarterly report2026-05-14
  4. 10-K Annual report2026-03-30
  5. 8-K Other event2026-02-26
  6. 8-K Officer / director change2026-02-19
  7. 8-K Officer / director change2026-02-13
  8. S-1 Securities registration2026-01-21

Recent filings

all on EDGAR ↗
425Filing2026-07-10open ↗SCHEDULE 13GFiling2026-07-06open ↗425Filing2026-07-06open ↗3Period ending 2026-06-262026-07-02open ↗3Period ending 2026-06-262026-07-02open ↗425Filing2026-07-02open ↗8-KPeriod ending 2026-06-262026-07-02open ↗425Filing2026-07-01open ↗SCHEDULE 13GFiling2026-06-30open ↗425Filing2026-06-29open ↗425Filing2026-06-26open ↗425Filing2026-06-26open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial healthF
Momentum—
  • ✓Liabilities below 2× equity
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

Total assets$154K
Total liabilities$175K
Stockholders' equity-$21.1K
L/E: -8.31x

Frequently asked

Is Columbus Circle Capital Corp II (CMIIU) a buy?
CMIIU currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -8.31x).
What is Columbus Circle Capital Corp II's quality score?
CMIIU scores 15/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

New filings change verdicts

The daily Brief delivers our freshest calls, rating flips and the filings behind them — every morning, free.

Sources: SEC EDGAR (CIK 0002088805, latest 10-Q filed 2026-05-14) · as of 7/15/2026, 7:30:48 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 15, 2026, 3:30 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Intraday
NVDA$209.23▼1.22%AAPL$327.82▲4.12%GOOGL$370.03▲2.93%GOOG$368.77▲3.20%MSFT$396.34▲2.96%AMZN$254.96▲3.02%TSM$417.95▼0.58%AVGO$391.94▲0.73%SPCX$134.77▼0.97%META$673.73▲1.92%TSLA$398.30▲0.54%MU$906.76▼7.77%BRK-A$734,704.78▼0.31%BRK-B$490.10▼0.20%LLY$1,146.65▼0.51%JPM$347.08▲1.22%WMT$113.86▲0.14%AMD$527.56▼3.75%ASML$1,790.43▲0.83%V$358.63▲0.73%JNJ$249.64▼1.66%XOM$143.08▼1.39%INTC$101.96▼5.38%MA$537.58▼0.08%AMAT$574.51▼3.56%CSCO$111.65▼4.65%LRCX$329.07▼4.92%ABBV$246.99▲0.90%CAT$903.41▼3.21%BAC$61.49▲1.44%
NVDA$209.23▼1.22%AAPL$327.82▲4.12%GOOGL$370.03▲2.93%GOOG$368.77▲3.20%MSFT$396.34▲2.96%AMZN$254.96▲3.02%TSM$417.95▼0.58%AVGO$391.94▲0.73%SPCX$134.77▼0.97%META$673.73▲1.92%TSLA$398.30▲0.54%MU$906.76▼7.77%BRK-A$734,704.78▼0.31%BRK-B$490.10▼0.20%LLY$1,146.65▼0.51%JPM$347.08▲1.22%WMT$113.86▲0.14%AMD$527.56▼3.75%ASML$1,790.43▲0.83%V$358.63▲0.73%JNJ$249.64▼1.66%XOM$143.08▼1.39%INTC$101.96▼5.38%MA$537.58▼0.08%AMAT$574.51▼3.56%CSCO$111.65▼4.65%LRCX$329.07▼4.92%ABBV$246.99▲0.90%CAT$903.41▼3.21%BAC$61.49▲1.44%
Intraday
NVDA$209.23▼1.22%AAPL$327.82▲4.12%GOOGL$370.03▲2.93%GOOG$368.77▲3.20%MSFT$396.34▲2.96%AMZN$254.96▲3.02%TSM$417.95▼0.58%AVGO$391.94▲0.73%SPCX$134.77▼0.97%META$673.73▲1.92%TSLA$398.30▲0.54%MU$906.76▼7.77%BRK-A$734,704.78▼0.31%BRK-B$490.10▼0.20%LLY$1,146.65▼0.51%JPM$347.08▲1.22%WMT$113.86▲0.14%AMD$527.56▼3.75%ASML$1,790.43▲0.83%V$358.63▲0.73%JNJ$249.64▼1.66%XOM$143.08▼1.39%INTC$101.96▼5.38%MA$537.58▼0.08%AMAT$574.51▼3.56%CSCO$111.65▼4.65%LRCX$329.07▼4.92%ABBV$246.99▲0.90%CAT$903.41▼3.21%BAC$61.49▲1.44%
NVDA$209.23▼1.22%AAPL$327.82▲4.12%GOOGL$370.03▲2.93%GOOG$368.77▲3.20%MSFT$396.34▲2.96%AMZN$254.96▲3.02%TSM$417.95▼0.58%AVGO$391.94▲0.73%SPCX$134.77▼0.97%META$673.73▲1.92%TSLA$398.30▲0.54%MU$906.76▼7.77%BRK-A$734,704.78▼0.31%BRK-B$490.10▼0.20%LLY$1,146.65▼0.51%JPM$347.08▲1.22%WMT$113.86▲0.14%AMD$527.56▼3.75%ASML$1,790.43▲0.83%V$358.63▲0.73%JNJ$249.64▼1.66%XOM$143.08▼1.39%INTC$101.96▼5.38%MA$537.58▼0.08%AMAT$574.51▼3.56%CSCO$111.65▼4.65%LRCX$329.07▼4.92%ABBV$246.99▲0.90%CAT$903.41▼3.21%BAC$61.49▲1.44%
Smart money○○○→

Smart moneyinsiders · Congress · funds

○○○

Disclosed smart-money activity in CMIIU, but no clear buy consensus.

—
Corporate insiders
No recent Form 4 activity
Form 4
—
Congress
No disclosed trades
STOCK Act · ~45d lag
—
Institutions
1 tracked fund hold · $20.00
13F · quarterly

Different disclosure clocks — Form 4s file within days, Congress PTRs lag up to ~45 days, and 13F holdings are a quarterly snapshot (up to ~4.5 months old). A disclosed-accumulation view, not live correlation.

Insider activityForm 4 · SEC

all insiders →
2026-02-12
COLUMBUS CIRCLE 2 SPONSOR Corp LLC
10% owner
Buy
265K @ $10.00$2.65M

Held by tracked fundsForm 13F · SEC · quarterly

Sculptor Capital2.00 sh$20.00

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Recent news

market news →
Columbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public OfferingBullish
globenewswire.com· 2026-02-10
SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock ExchangeBullish
globenewswire.com· 2021-09-01
SomaLogic expands leadership team with new positions to drive commercial successBullish
globenewswire.com· 2021-08-31
SomaLogic Provides 2021 Financial Guidance Exceeding Initial Merger Combination ProjectionsBullish
globenewswire.com· 2021-08-23
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodiesBullish
finance.yahoo.com· 2021-08-18
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodiesBullish
globenewswire.com· 2021-08-18

Vs tracked universe

compare →

1178 tracked peers · median

TENK Score15 vs 67
Revenue growth— vs 7.6%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.4